The neuropeptide calcitonin gene-related peptide (CGRP) plays a crucial role in migraine based on its efficacy of anti-CGRP treatment in clinical trials against headache, and CGRP administration triggers delayed migraine-like headache in patients with migraine [6, 14]. The gene discussed is CALCA; the disease is migraine disorder.